Jubilant Draximage Inc.
2 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 2 name spellings.
4
Ending by 2030
Dec 2026
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Jan 4, 2027The maintenance fee for Generator Columns for Elution Systems Loaded with Pre-Charged Matrix (US 11,694,818) comes due Jan 4, 2027. Unpaid by Jul 6, 2027, it lapses early.
- 1 fee due Apr 17, 2027The maintenance fee for Elution Protocols and Dosages for Radiopharmaceutical Elution System (US 11,791,060) comes due Apr 17, 2027. Unpaid by Oct 18, 2027, it lapses early.
- 1 fee due Jul 2, 2027The maintenance fee for Pharmaceutical composition comprising tetrofosmin and pharmaceutically acceptable salts thereof (US 11,857,647) comes due Jul 2, 2027. Unpaid by Jan 3, 2028, it lapses early.
- 1 fee due Aug 20, 2027The maintenance fee for Security mechanisms for radiopharmaceutical elution system and elution process (US 11,904,028) comes due Aug 20, 2027. Unpaid by Feb 22, 2028, it lapses early.
Recent changes
- 1 of the patents on this record was granted since Aug 17, 2026
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,700,926 | Systems and Methods for Radioisotope Generation In force (reinstated) · High confidence | In force (reinstated) | High confidence | |
| US 8,143,592 | Filling system for potentially hazardous materials In force · From the USPTO record | In force | From the USPTO record | |
| US 7,563,920 | Methods for preparing 2-methoxyisobutylisonitrile and tetrakis(2-methoxyisobutylisonitrile)copper(I) tetrafluoroborate In force · From the USPTO record | In force | From the USPTO record | |
| US 7,750,328 | Filling system for potentially hazardous materials In force · From the USPTO record | In force | From the USPTO record | |
| US 12,451,265 | Rubidium elution system control In force · From the USPTO record | In force | From the USPTO record | |
| US 10,252,986 | Process for the Preparation of Exametazime In force · High confidence | In force | High confidence | |
| US D934,418 | Shielding syringe holder In force · From the USPTO record | In force | From the USPTO record | |
| US D934,419 | Syringe holding device In force · From the USPTO record | In force | From the USPTO record | |
| US 10,836,781 | Process for the preparation of tetrofosmin or acid salt thereof In force · From the USPTO record | In force | From the USPTO record | |
| US 11,857,647 | Pharmaceutical composition comprising tetrofosmin and pharmaceutically acceptable salts thereof In force · From the USPTO record | In force | From the USPTO record |
Also on record, not counted in the 34: 2 patents in force now held by others · 4 lapsed for an unpaid fee · 7 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
10 pending · 8 abandoned · 1 no status recorded